• Users Online: 45179
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series
Eduardo A. Novais,Emmerson Badaró,Flavio E. Hirai,Felipe Abdo Jorge,Paula Leal,Michel Eid Farah,Eduardo B. Rodrigues
Journal of Ophthalmology.2016;2016()1
[DOI]
2Intravitreal Triamcinolone Acetonide in the Treatment of Ophthalmic Inflammatory Diseases with Macular Edema: A Meta-Analysis Study
Claudio Bucolo,Giuseppe Grosso,Valentina Drago,Caterina Gagliano
Journal of Ocular Pharmacology and Therapeutics.2015;31(4)228
[DOI]
3Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema
Taygan Yilmaz,Miguel Cordero-Coma,Thomas J Federici
Expert Opinion on Drug Metabolism & Toxicology.2011;7(10)1327
[DOI]
4Clinical Applications of Dexamethasone for Aged Eyes
Beatriz Abadia,Pilar Calvo,Antonio Ferreras,Fran Bartol,Guayente Verdes,Luis Pablo
Drugs & Aging.2016;33(9)639
[DOI]
5Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications
M.L. Formica,G.V. Ullio Gamboa,L.I. Tártara,J.D. Luna,J.P. Benoit,S.D. Palma
International Journal of Pharmaceutics.2020;573(9)118795
[DOI]
6Retinal pseudoangiitis after intravitreal triamcinolone
J. M. Garcia-Campos,I. Garcia-Basterra,R. Kamal-Salah,I. Baquero-Aranda
Case Reports.2015;2015(feb12 1)bcr2014206286
[DOI]
7Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Jose Navarro-Partida,Juan Carlos Altamirano-Vallejo,Luis Abraham Aceves Franco,Jesús Gonzalez-Cortes,Sergio Hernandez-Da Mota,Jose Gerardo García-Aguirre,Carlos David Azuara-Galindo,Carlos Rodrigo Castro-Castaneda,Juan Armendariz-Borunda,Arturo Santos
Pharmaceutics.2021;13(9)1491
[DOI]
8Permeability, anti-inflammatory and anti-VEGF profiles of steroidal-loaded cationic nanoemulsions in retinal pigment epithelial cells under oxidative stress
Ana R. Fernandes,Tiago dos Santos,Pedro L. Granja,Elena Sanchez-Lopez,Maria L. Garcia,Amelia M. Silva,Eliana B. Souto
International Journal of Pharmaceutics.2022;617(9)121615
[DOI]
9Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review
Yan Lv,Chenglei Zhai,Gang Sun,Yangfang He
Journal of Biological Engineering.2024;18(1)121615
[DOI]
10Clearance of autophagy-associated dying retinal pigment epithelial cells – a possible source for inflammation in age-related macular degeneration
M Szatmári-Tóth,E Kristóf,Z Veréb,S Akhtar,A Facskó,L Fésüs,A Kauppinen,K Kaarniranta,G Petrovski
Cell Death & Disease.2016;7(9)e2367
[DOI]
11Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment
Marieke Veurink,Cinzia Stella,Cyrus Tabatabay,Constantin J. Pournaras,Robert Gurny
European Journal of Pharmaceutics and Biopharmaceutics.2011;78(2)271
[DOI]
12Nanoformulations of flavonoids for diabetes and microvascular diabetic complications
Kopal Agarawal,Yogesh Anant Kulkarni,Sarika Wairkar
Drug Delivery and Translational Research.2023;13(1)18
[DOI]
13Drug safety evaluation of intravitreal triamcinolone acetonide
Daniele Veritti,Andrea Di Giulio,Valentina Sarao,Paolo Lanzetta
Expert Opinion on Drug Safety.2012;11(2)331
[DOI]
14Crystalline retinopathy: Unifying pathogenic pathways of disease
Jaclyn L. Kovach,Hacer Isildak,David Sarraf
Survey of Ophthalmology.2019;64(1)1
[DOI]
15Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab
Pilar Calvo,Antonio Ferreras,Fadwa Al Adel,Yao Wang,Michael H Brent
British Journal of Ophthalmology.2015;99(6)723
[DOI]
16Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration
Anjali Hirani,Aditya Grover,Yong W. Lee,Yashwant Pathak,Vijaykumar Sutariya
Pharmaceutical Development and Technology.2016;21(1)61
[DOI]
17Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells
Siva P. Kambhampati,Manoj K. Mishra,Panagiotis Mastorakos,Yumin Oh,Gerard A. Lutty,Rangaramanujam M. Kannan
European Journal of Pharmaceutics and Biopharmaceutics.2015;95(1)239
[DOI]
18Similar Products at Different Prices: Can Biopharmaceutical Companies Segment Markets?
Richard Manning,Christopher Stomberg,Benjamin Scher,Kathleen Twigg,Andrew Huson
International Journal of the Economics of Business.2015;22(2)231
[DOI]
19Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone for Therapy-Resistant Exudative Age-Related Macular Degeneration
Yong Tao,Jost B. Jonas
Journal of Ocular Pharmacology and Therapeutics.2010;26(2)207
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal